CAM
GSK icon

Cidel Asset Management’s GSK GSK Stock Holding History

Cidel Asset Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,000
Closed -$200K – 125
2019
Q2 		$200K Hold
4,000
– – 0.01% 106
2019
Q1 		$209K Buy
+4,000
New +$200K 0.01% 126

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.78B AUM 5.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Cidel Asset Management's GSK Position: Q3 2019 in Review

Cidel Asset Management sold out of GSK (GSK) in Q3 2019, closing a stake of 4,000 shares — an estimated $200K sold.

Cidel Asset Management first reported a position in GSK in Q1 2019 and held it in 2 quarters. The position peaked at $209K in Q1 2019. 806 funds tracked by Wall St. Rank hold GSK as of Q3 2019.

  • Cidel Asset Management reported no remaining GSK position as of Q3 2019 after selling out during the quarter.
  • Cidel Asset Management sold 4,000 GSK shares in Q3 2019, an estimated $200K.
  • Cidel Asset Management first reported a position in GSK in Q1 2019 and held it in 2 quarters.
  • Cidel Asset Management's GSK position peaked at $209K in Q1 2019.
  • 806 funds tracked by Wall St. Rank held GSK as of Q3 2019.

Based on Cidel Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.